Granules India Limited

NSE:GRANULES.NS

584.5 (INR) • At close November 8, 2024
Bedrijfsnaam Granules India Limited
Symbool GRANULES.NS
Munteenheid INR
Prijs 584.5
Beurswaarde 141,664,680,500
Dividendpercentage 0.38%
52-weken bereik 360.1 - 721
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
Website https://www.granulesindia.com

An error occurred while fetching data.

Over Granules India Limited

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also

Vergelijkbare Aandelen

Jubilant Pharmova Limited logo

Jubilant Pharmova Limited

JUBLPHARMA.NS

1,239 INR

AstraZeneca Pharma India Limited logo

AstraZeneca Pharma India Limited

ASTRAZEN.NS

7,306.8 INR

Poly Medicure Limited logo

Poly Medicure Limited

POLYMED.NS

2,781 INR

Sun Pharma Advanced Research Company Limited logo

Sun Pharma Advanced Research Company Limited

SPARC.NS

207.44 INR

Procter & Gamble Health Limited logo

Procter & Gamble Health Limited

PGHL.NS

5,570.2 INR

Jubilant Ingrevia Limited logo

Jubilant Ingrevia Limited

JUBLINGREA.NS

712.05 INR

Caplin Point Laboratories Limited logo

Caplin Point Laboratories Limited

CAPLIPOINT.NS

2,011.8 INR

Glenmark Life Sciences Limited logo

Glenmark Life Sciences Limited

GLS.NS

1,096.1 INR

Hikal Limited logo

Hikal Limited

HIKAL.NS

386.95 INR

Metropolis Healthcare Limited logo

Metropolis Healthcare Limited

METROPOLIS.NS

2,115.45 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)